SMTI

Sanara MedTech (SMTI)

About Sanara MedTech (SMTI)

Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Details

Daily high

$21.98

Daily low

$20.97

Price at open

$21.83

52 Week High

$35.95

52 Week Low

$16.05

Market cap

201.8M

Dividend yield

0.00%

Volume

76,016

Avg. volume

56,236

P/E ratio

-5.66

Sanara MedTech News